Search for a trial

Optimal delay for hepatobiliary phase MRI with gadobenate dimeglumine

To analyze the percentage of HCA becoming hypointens 20-25-30-35-40-45 minutes after IV contrast injection of gadobenate dimeglumine.

Contrast Enhanced Ultrasound and Urine Mass Spectometry in Patients with Hepatocellular Adenoma

The purpose of this study is to improve the diagnosis and management of hepatocellular adenoma.

Genetic and Radiological Screening of First Degree Family Members of Patients with Familial Liver Adenomatosis

To determine if LA is a familial disease. To identify germline mutations in HNF-1 alpha, ß-catenin and CYP1B1 genes in LA patients. To screen first degree relatives of patients diagnosed with liver adenomatosis for the presence of liver adenomas and…

Validation of MRI with Primovist® for Differentiation of Hepatocellular Adenoma and Focal Nodular Hyperplasia

Validation of MRI with Primovist® for differentiation of FNH and HCA.Do imaging and histological outcome correlate?Is it possible to use MRI with Primovist® (as gold standard) in the diagnostic work-up of FNH and HCA?

KETOgenic diet therapy in patients with HEPatocellular adenoma

to determine the effect of dietary restriction and the ketogenic diet on the regression of hepatocellular adenoma after 6 months.

Primovist CT: proof of concept

To show differences in uptake of Primovist between FNHs and hepatocellular adenomas on CT.

Transarterial embolization of non-bleeding hepatocellular adenomas: a pilot study

To gain insight into the effects of TAE on HCAs and their behavior post-embolisation.

Cholangiocarcinoma detection using an intraOperative
FlUorescence Image Guided Approach with
Bevacizumab-IRDye 800CW

PrimairyTo assess whether bevacizumab-800CW allows for intraoperative fluorescence imaging of perihilar cholangiocarcinoma and what dose provides the best visualization of tumor tissue by determining the tumor-to-background (TBR) ratio ex…